Published in

Springer Verlag, Journal of Neurology, 8(256), p. 1379-1381

DOI: 10.1007/s00415-009-5138-y

Links

Tools

Export citation

Search in Google Scholar

CCL8/MCP-2 association analysis in patients with Alzheimer's disease and frontotemporal lobar degeneration

Journal article published in 2009 by Chiara Villa, Eliana Venturelli, Chiara Fenoglio, Francesca Clerici, Alessandra Marcone, Luisa Benussi ORCID, Roberta Ghidoni ORCID, Salvatore Gallone, Francesca Cortini, Diego Scalabrini, Maria Serpente, Giuliano Binetti, Stefano Cappa, Claudio Mariani, Innocenzo Rainero and other authors.
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

CCL2/Monocyte Chemoattractant Protein (MCP)-1 and other chemokines sharing a similar sequence, including CCL8/MCP-2, are involved in neurodegeneration. A few Single Nucleotide Polymorphisms (SNPs) have been reported in CCL8/MCP-2, all of which are located in the same linkage block. One of them (rs1163763) leads to an aminoacidic substitution, implying a potential impact on the function of the protein. rs1133763 was tested for association in 219 patients with Alzheimer's disease (AD) and 209 with Frontotemporal Lobar Degeneration (FTLD) as compared with 231 age-matched controls. The distribution of CCL8/MCP-2 rs1133763 was not significantly different among patients with AD or FTLD and controls, even stratifying according to gender. CCL8/MCP rs1133763 SNP, or other variants in linkage disequilibrium with this variant, likely do not influence the susceptibility to AD or FTLD in Caucasians.